Mitomycin Supplier-Buyer Network — Trade Flow Analysis

Name: Mitomycin Supplier-Buyer Trade Network Dataset — 213+ Indian Exporters, 14+ Importers, 103+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Mitomycin supplier network, Mitomycin buyers, pharmaceutical export India, Mitomycin trade data

TransData Nexus

Mitomycin

India Pharmaceutical Trade Intelligence

$8.2M213 Suppliers103 CountriesHS 30049049

ExportsIndia → UNITED STATES63.5%India → ALGERIA7.5%

ImportsUNITED STATES → India$69.3K UNITED KINGDOM → India$7.0K

#1 Supplier: INTAS PHARMACEUTICALS #1 Buyer: RX CROSSROADS

Who Supplies Mitomycin? Top Manufacturers & Buyers 2026 — INTAS PHARMACEUTICALS LIMITED Leads | TransData Nexus | TransData Nexus

1INTAS PHARMACEUTICALS LIMITED

INTAS PHARMACEUTICALS LIMITED is the first-largest Mitomycin exporter from India, with a market share of 23.5% and a total export value of $1.9M across 46 shipments. Their average shipment value of $41.7K is above the market average of $6.1K, suggesting premium or bulk contract pricing.

INTAS PHARMACEUTICALS LIMITED serves 5 named buyers in our database. TO THE ORDER is the dominant customer, accounting for 54.5% of this supplier's tracked business. Top customers include:

• TO THE ORDER — $1.0M across 25 shipments (54.5% of this supplier's total exports)

• FOUNDATION CARE — $432.5K across 10 shipments (22.6% of this supplier's total exports)

• B BRAUN MEDICAL INC — $222.2K across 5 shipments (11.6% of this supplier's total exports)

• FOUNDATION CARE — $128.1K across 3 shipments (6.7% of this supplier's total exports)

• XXOWAXXIRIXXCO XXLIMITEDX — $88.9K across 2 shipments (4.6% of this supplier's total exports)

Key Insight: INTAS PHARMACEUTICALS LIMITED's per-shipment value of $41.7K is 581% above the market average of $6.1K, consistent with large-order contracts or value-added formulations.

2MYLAN LABORATORIES LIMITED

MYLAN LABORATORIES LIMITED is the second-largest Mitomycin exporter from India, with a market share of 22.9% and a total export value of $1.9M across 25 shipments. Their average shipment value of $74.6K is above the market average of $6.1K, suggesting premium or bulk contract pricing.

MYLAN LABORATORIES LIMITED serves 2 named buyers in our database. RX CROSSROADS 3PL LLC is the dominant customer, accounting for 65.5% of this supplier's tracked business. Top customers include:

• RX CROSSROADS 3PL LLC — $1.2M across 16 shipments (65.5% of this supplier's total exports)

• RXCROSSROADS 3PL LLC — $643.8K across 9 shipments (34.5% of this supplier's total exports)

Key Insight: MYLAN LABORATORIES LIMITED's per-shipment value of $74.6K is 1119% above the market average of $6.1K, consistent with large-order contracts or value-added formulations.

3INTAS PHARMACEUTICALS LTD

INTAS PHARMACEUTICALS LTD is the third-largest Mitomycin exporter from India, with a market share of 6.8% and a total export value of $558.1K across 7 shipments. Their average shipment value of $79.7K is above the market average of $6.1K, suggesting premium or bulk contract pricing.

INTAS PHARMACEUTICALS LTD serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• ACCORD HEALTHCARE IN — $245.8K across 3 shipments (44.0% of this supplier's total exports)

• KYOWA KIRIN CO LTD — $215.7K across 3 shipments (38.7% of this supplier's total exports)

• ACCORD HEALTHCARE PO — $57.6K across 1 shipments (10.3% of this supplier's total exports)

• XXcorXXHeaXXhcaXX B — $39.0K across 0 shipments (7.0% of this supplier's total exports)

• EUROFINS ANALYTICAL — $12 across 0 shipments (0.0% of this supplier's total exports)

Key Insight: INTAS PHARMACEUTICALS LTD's per-shipment value of $79.7K is 1203% above the market average of $6.1K, consistent with large-order contracts or value-added formulations.

4NAPROD LIFE SCIENCES PVT LTD

NAPROD LIFE SCIENCES PVT LTD is the fourth-largest Mitomycin exporter from India, with a market share of 4.1% and a total export value of $335.8K across 10 shipments. Their average shipment value of $33.6K is above the market average of $6.1K, suggesting premium or bulk contract pricing.

NAPROD LIFE SCIENCES PVT LTD serves 2 named buyers in our database. ATLANTA MEDICARE CO. LTD. is the dominant customer, accounting for 55.7% of this supplier's tracked business. Top customers include:

• ATLANTA MEDICARE CO. LTD. — $187.1K across 6 shipments (55.7% of this supplier's total exports)

• PHARMACIE CENTRALE DES HOPITAUX (P — $148.7K across 4 shipments (44.3% of this supplier's total exports)

Key Insight: NAPROD LIFE SCIENCES PVT LTD's per-shipment value of $33.6K is 449% above the market average of $6.1K, consistent with large-order contracts or value-added formulations.

5EUGIA PHARMA SPECIALITIES LIMITED

EUGIA PHARMA SPECIALITIES LIMITED is the fifth-largest Mitomycin exporter from India, with a market share of 4.0% and a total export value of $329.1K across 8 shipments. Their average shipment value of $41.1K is above the market average of $6.1K, suggesting premium or bulk contract pricing.

EUGIA PHARMA SPECIALITIES LIMITED serves 2 named buyers in our database. EUGIA US LLC is the dominant customer, accounting for 73.7% of this supplier's tracked business. Top customers include:

• EUGIA US LLC — $242.5K across 6 shipments (73.7% of this supplier's total exports)

• EUGIA US LLC — $86.6K across 2 shipments (26.3% of this supplier's total exports)

Key Insight: EUGIA PHARMA SPECIALITIES LIMITED's per-shipment value of $41.1K is 572% above the market average of $6.1K, consistent with large-order contracts or value-added formulations.

6NAPROD LIFE SCIENCES PRIVATE LIMITED

NAPROD LIFE SCIENCES PRIVATE LIMITED is the fifth-largest Mitomycin exporter from India, with a market share of 3.9% and a total export value of $316.3K across 19 shipments. Their average shipment value of $16.6K is above the market average of $6.1K, suggesting premium or bulk contract pricing.

NAPROD LIFE SCIENCES PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• PHARMACIE CENTRALE DES HOPITAUX (P — $129.9K across 8 shipments (41.1% of this supplier's total exports)

• PHARMACIE CENTRALE DES HOPITAUX (P — $73.4K across 4 shipments (23.2% of this supplier's total exports)

• ATLANTA MEDICARE CO. LTD. — $50.7K across 3 shipments (16.0% of this supplier's total exports)

• ATLANTA MEDICARE CO. LTD. — $38.9K across 2 shipments (12.3% of this supplier's total exports)

• I & C (HONGKONG) LIM — $23.4K across 1 shipments (7.4% of this supplier's total exports)

Key Insight: NAPROD LIFE SCIENCES PRIVATE LIMITED's per-shipment value of $16.6K is 172% above the market average of $6.1K, consistent with large-order contracts or value-added formulations.

1United States

United States ranks as the first-largest destination for Mitomycin imports from India, with a total trade value of $5.2M across 57 shipments — representing a 63.5% share of all Mitomycin exports. The average shipment value of $90.9K is above the global average of $6.1K, indicating high-value procurement contracts or branded formulations. This market is served by 8 tracked buyers.

Named Mitomycin importers in United States: RX CROSSROADS 3PL LLC is the largest buyer, accounting for 34.3% ($1.8M) of this market's total imports.

• RX CROSSROADS 3PL LLC — $1.8M (34.3% of United States's total)

• RXCROSSROADS 3PL LLC — $643.8K (12.4% of United States's total)

• FOUNDATION CARE — $432.5K (8.3% of United States's total)

Key Insight: United States's per-shipment average of $90.9K (1385% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United States is a key market for Mitomycin imports from India.

Primary Market

Secondary Market

2Algeria

Algeria ranks as the second-largest destination for Mitomycin imports from India, with a total trade value of $611.7K across 9 shipments — representing a 7.5% share of all Mitomycin exports. The average shipment value of $68.0K is above the global average of $6.1K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.

Named Mitomycin importers in Algeria: PHARMACIE CENTRALE DES HOPITAUX (PC is the largest buyer, accounting for 63.7% ($389.6K) of this market's total imports.

• PHARMACIE CENTRALE DES HOPITAUX (PC — $389.6K (63.7% of Algeria's total)

• PHARMACIE CENTRALE DES HOPITAUX — $148.7K (24.3% of Algeria's total)

• PHARMACIE CENTRALE DES HOPITAUX (P — $73.4K (12.0% of Algeria's total)

Key Insight: Algeria's per-shipment average of $68.0K (1011% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Algeria is a key market for Mitomycin imports from India.

Primary Market

Secondary Market

3Thailand

Thailand ranks as the third-largest destination for Mitomycin imports from India, with a total trade value of $427.5K across 13 shipments — representing a 5.2% share of all Mitomycin exports. The average shipment value of $32.9K is above the global average of $6.1K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Mitomycin importers in Thailand: ATLANTA MEDICARE CO LTD is the largest buyer, accounting for 52.9% ($226.0K) of this market's total imports.

• ATLANTA MEDICARE CO LTD — $226.0K (52.9% of Thailand's total)

• ATLANTA MEDICARE CO. LTD. — $149.1K (34.9% of Thailand's total)

Key Insight: Thailand's per-shipment average of $32.9K (437% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Thailand is a key market for Mitomycin imports from India.

Primary Market

Secondary Market

4Japan

Japan ranks as the fourth-largest destination for Mitomycin imports from India, with a total trade value of $322.0K across 5 shipments — representing a 3.9% share of all Mitomycin exports. The average shipment value of $64.4K is above the global average of $6.1K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Mitomycin importers in Japan: KYOWA KIRIN CO LTD is the largest buyer, accounting for 67.0% ($215.7K) of this market's total imports.

• KYOWA KIRIN CO LTD — $215.7K (67.0% of Japan's total)

• XXOWAXXIRIXXCO XXLIMITEDX — $88.9K (27.6% of Japan's total)

Key Insight: Japan's per-shipment average of $64.4K (952% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Japan is a key market for Mitomycin imports from India.

Primary Market

Secondary Market

5Canada

Canada ranks as the fifth-largest destination for Mitomycin imports from India, with a total trade value of $245.8K across 0 shipments — representing a 3.0% share of all Mitomycin exports. The average shipment value of $245.8K is above the global average of $6.1K, indicating high-value procurement contracts or branded formulations.

Key Insight: Canada's per-shipment average of $245.8K (3917% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Canada is a key market for Mitomycin imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Mitomycin.
2.Flow Mapping: 213 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 1,333 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 103 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

1,333 Verified Shipments

213 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Mitomycin

Mitomycin

Who Supplies Mitomycin? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Market Intelligence

Official References & Regulatory Resources

Who Supplies Mitomycin? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Mitomycin Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1INTAS PHARMACEUTICALS LIMITED

2MYLAN LABORATORIES LIMITED

3INTAS PHARMACEUTICALS LTD

4NAPROD LIFE SCIENCES PVT LTD

5EUGIA PHARMA SPECIALITIES LIMITED

6NAPROD LIFE SCIENCES PRIVATE LIMITED

From Indian Factories to Global Pharmacies — How Mitomycin Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Mitomycin Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1United States

2Algeria

3Thailand

4Japan

5Canada

People Also Ask — Mitomycin Supplier & Trade Network

Mitomycin Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology